Commission pledges to clarify in-house manufacture issues
This article was originally published in Clinica
Executive Summary
The European Commission has drafted a proposed new definition of "in-house products", a term that generally applies to products manufactured by hospitals for their own use. It is aiming to help create a better understanding of how the EU medical device directives affect these products and also put an end to the current confusion about the extent to which they are regulated.